A Benefit-Risk Assessment of Inhaled Long-Acting ??2-Agonists in the Management of Obstructive Pulmonary Disease

Journal

  • Drug Safety

    Drug Safety 27 (10), 689-715, 2004

    Springer Science and Business Media LLC

Citations (1)*help

See more

Details 詳細情報について

Report a problem

Back to top